The Latest Cardiac and Vascular News
ContraBand™ technology helps restore the heart’s functionality and may significantly improve patients’ quality of life OR YEHUDA, Israel, Dec. 7, 2021 /PRNewswire/ — Restore Medical Ltd., a clinical-stage MedTech company developing cardiac implants for the treatment of congestive heart failure (CHF), today announced promising preliminary results of the First-in-Human clinical trial of ContraBand™, a breakthrough treatment […]
Anthos Therapeutics announces that 1287 patients enrolled across 95 global study sites in the AZALEA-TIMI 71 Ph2 study evaluating the safety and tolerability of abelacimab compared to rivaroxaban Abelacimab is a monoclonal antibody with dual activity against Factor XI and Factor XIa administered monthly CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ — Anthos Therapeutics, […]
SAFE-MCS Will Examine the Impact of the Early Bird® Bleed Monitoring System on Reducing Bleeding Complications in Patients Undergoing High Risk PCI with Mechanical Circulatory Support HOUSTON–(BUSINESS WIRE)–Saranas, Inc., has announced initiation and first patient enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk […]
BEDMINSTER, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (LNC) platform delivery technology, today announced the appointment of Thomas Hoover to the newly created position of Chief Business Officer. […]
Trial studying communication between cardiac rhythm management devices aims to expand treatment options for patients who require an ICD MARLBOROUGH, Mass., Dec. 2, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM™ Modular Therapy System. The mCRM […]
Acquisition expands Integer’s cardiovascular and neurostimulation product portfolio through broadened product offering and addition of low-cost manufacturing capacity PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of Oscor, Inc., a privately-held […]
UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of protein biomarkers in the empagliflozin EMPEROR studies, recently entered the data analysis phase. Empagliflozin, approved in the US under the tradename JARDIANCE, […]
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 30, 2021 it granted stock options to purchase an aggregate of 143,500 shares of common stock to 9 new employees, whose employment commenced in November 2021, as a material inducement to […]
Gold Coast, Queensland, Australia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Cholrem (Australia) Pty Ltd have produced a product CAVADEX (Beta-Cyclodextrin) which reverses heart disease by removing cholesterol from damaged and narrowed arteries after only a few months, resulting in reduced arterial plaque. Atherosclerosis, also known as heart disease, is the […]
Former Medtronic Executive Brings Significant Experience in Cardiac and Remote Patient Monitoring to Help Deliver Qardio’s Mission to Transform Cardiac and Chronic Care AMSTERDAM & SAN FRANCISCO–(BUSINESS WIRE)–Qardio, Inc. (“Qardio” or “Company”), a medical technology company that operates at the intersection of cardiology and remote patient monitoring, today announced the Company’s […]
